Fairvalue-Calculator Fairvalue-Calculator
EN DE

Branded Legacy Inc (BLEG) Fair Value & Analysis

Healthcare · US · Market cap $55.0K

Price$0.0270
Fair Value$0.0294
Upside+8.8%
Quality95/100
Evidence: Low Range $0.0263 – $0.0325

Fair value as of: Jun 26, 2026

Analysis

Branded Legacy Inc (BLEG) currently trades at $0.0270, while our model-based Fair Value estimate is $0.0294 — implying the stock looks roughly 8.8% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Branded Legacy Inc engages in the commercial development of hemp and cannabinoid-infused beverages in Central Florida. It provides CBD topicals and tinctures, and hemp coffees and teas. The company was formerly known as Elev8 Brands, Inc. and changed its name to Branded Legacy Inc in May 2020. Branded Legacy Inc. was incorporated in 1981 and is headquartered in Melbourne, Florida.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +1949% Jiangsu Hengrui Pharmaceuticals Co (600276) -46% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -74% Hansoh Pharmaceutical Group (3692) -47% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Branded Legacy Inc (BLEG) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0294 versus a price of $0.0270 — about +9% (undervalued). Model-based estimate, not financial advice.
What is the fair value of BLEG?
Our 21-model fair value for Branded Legacy Inc is $0.0294 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0270.
What is the quality score of BLEG?
Branded Legacy Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.